NCI Discontinues Funding for Pediatric Brain Cancer Program, Shifting Focus to For-Profit Entities like CNS Pharmaceuticals Inc.
Update: 2025-09-05
Description
The NCI has ended funding for a long-standing pediatric brain cancer program, emphasizing the role of for-profit companies like CNS Pharmaceuticals Inc. in driving research forward. Investors can stay informed on CNS Pharmaceuticals Inc. through the company's newsroom, while BioMedWire offers a platform for communication and news distribution in the Biotechnology, Biomedical Sciences, and Life Sciences sectors.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
